Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pacira BioSciences, Inc. - Common Stock
(NQ:
PCRX
)
22.69
-0.57 (-2.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pacira BioSciences, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Investors should take notice of NASDAQ:PCRX—it offers a great deal for the fundamentals it presents.
↗
November 29, 2023
Despite its impressive fundamentals, PACIRA BIOSCIENCES INC (NASDAQ:PCRX) remains undervalued.
Via
Chartmill
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
November 10, 2023
From
Pacira BioSciences
Via
GlobeNewswire
For those who appreciate value investing, NASDAQ:PCRX is a compelling option with its solid fundamentals.
↗
November 08, 2023
Investors should take notice ofPACIRA BIOSCIENCES INC (NASDAQ:PCRX)—it offers a great deal for the fundamentals it presents.
Via
Chartmill
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
November 07, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Earnings Preview: Pacira BioSciences
↗
November 01, 2023
Via
Benzinga
Analyst Expectations for Pacira BioSciences's Future
↗
October 23, 2023
Via
Benzinga
4 Analysts Have This to Say About Pacira BioSciences
↗
August 03, 2023
Via
Benzinga
Analyst Ratings for Pacira BioSciences
↗
July 13, 2023
Via
Benzinga
Pacira BioSciences Reports Third Quarter 2023 Financial Results
November 02, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
October 26, 2023
From
Pacira BioSciences
Via
GlobeNewswire
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
October 12, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
October 10, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Looking Into Pacira BioSciences's Return On Capital Employed
↗
May 09, 2023
Via
Benzinga
Recap: Pacira BioSciences Q1 Earnings
↗
May 03, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Pacira BioSciences
↗
April 20, 2023
Via
Benzinga
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
October 02, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Announces Leadership Succession Plan
September 26, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
↗
September 26, 2023
On Tuesday, 386 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
September 11, 2023
Monday's session saw 175 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
↗
August 03, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
September 08, 2023
Friday's session saw 225 companies set new 52-week lows.
Via
Benzinga
Pacira BioSciences Reports Second Quarter 2023 Financial Results
August 02, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
July 26, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
May 31, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
May 09, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Why Pacira BioSciences Shares Are Trading Lower Today
↗
May 03, 2023
Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the
Via
Benzinga
Pacira BioSciences Reports First Quarter 2023 Financial Results
May 03, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
April 26, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
April 20, 2023
PGA TOUR Champions Golfer, Paul Goydos, Promotes Further Awareness of Non-Opioids with 2023 Partnership
From
Pacira BioSciences
Via
GlobeNewswire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
